Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pravin Jadhav

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Biology Reports|March 3, 2023
Morphological and microsatellite marker-based characterization and diversity analysis of novel vegetable soybean [Glycine max (L.) Merrill]Priya Pardeshi, Pravin Jadhav, Sanjay Sakhare, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 1, 2015
Reporting guidelines for population pharmacokinetic analysesKevin Dykstra, Nitin Mehrotra, Christoffer Wenzel Tornøe, et al.
Pediatric Nephrology (Berlin, Germany)|December 13, 2023
Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptanDjalila Mekahli, Lisa M Guay-Woodford, Melissa A Cadnapaphornchai, et al.
Journal of Clinical Pharmacology|July 8, 2015
Reporting guidelines for population pharmacokinetic analysesKevin Dykstra, Nitin Mehrotra, Christoffer Wenzel Tornøe, et al.
Clinical Pharmacology in Drug Development|May 17, 2024
A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular RiskChenna Keshava Reddy Sannala, Carol MacLean, Finn Larsen, et al.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Why did the FDA approve efavirenz 800 mg when co-administered with rifampin?Jiang Liu, Kirk M Chan-Tack, Pravin Jadhav, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Knowledge management for efficient quantitative analyses during regulatory reviewsKevin Krudys, Fang Li, Jeffry Florian, et al.
Critical Reviews in Food Science and Nutrition|October 22, 2020
Unexplored nutritive potential of tomato to combat global malnutritionSanskriti Vats, Ruchi Bansal, Nitika Rana, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Biology Reports|March 3, 2023
Morphological and microsatellite marker-based characterization and diversity analysis of novel vegetable soybean [Glycine max (L.) Merrill]Priya Pardeshi, Pravin Jadhav, Sanjay Sakhare, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 1, 2015
Reporting guidelines for population pharmacokinetic analysesKevin Dykstra, Nitin Mehrotra, Christoffer Wenzel Tornøe, et al.
Pediatric Nephrology (Berlin, Germany)|December 13, 2023
Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptanDjalila Mekahli, Lisa M Guay-Woodford, Melissa A Cadnapaphornchai, et al.
Journal of Clinical Pharmacology|July 8, 2015
Reporting guidelines for population pharmacokinetic analysesKevin Dykstra, Nitin Mehrotra, Christoffer Wenzel Tornøe, et al.
Clinical Pharmacology in Drug Development|May 17, 2024
A Model-Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular RiskChenna Keshava Reddy Sannala, Carol MacLean, Finn Larsen, et al.
Journal of Clinical Pharmacology|July 2, 2016
Utility of Model-Based Approaches for Informing Dosing Recommendations in Specific Populations: Report From the Public AAPS WorkshopIslam R Younis, J Robert Powell, Amin Rostami-Hodjegan, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Why did the FDA approve efavirenz 800 mg when co-administered with rifampin?Jiang Liu, Kirk M Chan-Tack, Pravin Jadhav, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Knowledge management for efficient quantitative analyses during regulatory reviewsKevin Krudys, Fang Li, Jeffry Florian, et al.
Critical Reviews in Food Science and Nutrition|October 22, 2020
Unexplored nutritive potential of tomato to combat global malnutritionSanskriti Vats, Ruchi Bansal, Nitika Rana, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Pageof 3